Synthesis and evaluation of Na /K -ATP-ase inhibiting and cytotoxic in vitro activities of oleandrigenin and its selected 17β-(butenolidyl)- and 17β-(3-furyl)- analogues
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F20%3A73604955" target="_blank" >RIV/61989592:15310/20:73604955 - isvavai.cz</a>
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S022352342030492X" target="_blank" >https://www.sciencedirect.com/science/article/pii/S022352342030492X</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejmech.2020.112520" target="_blank" >10.1016/j.ejmech.2020.112520</a>
Alternative languages
Result language
angličtina
Original language name
Synthesis and evaluation of Na /K -ATP-ase inhibiting and cytotoxic in vitro activities of oleandrigenin and its selected 17β-(butenolidyl)- and 17β-(3-furyl)- analogues
Original language description
Natural cardiac-active principles built upon the 14,16 beta-dihydroxy-5 beta,14 beta-androstane core and bearing a heterocyclic substituent at 17 beta, in particular, a cardenolide - oleandrin and a bufadienolide - bufotalin, are receiving a great deal of attention as potential anticancer drugs. The densely substituted and sterically shielded ring D is the particular structural feature of these compounds. The first synthesis of oleandrigenin from easily available steroid starting material is reported here. Furthermore, selected 17 beta-(4-butenolidyl)- and 17 beta-(3-furyl)-14,16 beta-dihydroxy-androstane derivatives were en route synthesized and examined for their Na+/K+-ATP-ase inhibitory properties as well as cytotoxic activities in normal and cancer cell lines. It was found that the furyl-analogue of oleandrigenin/bufatalin (7) and some related 17-(3-fury[)- derivatives (19, 21) show remarkably high Na+/K+-ATP-ase inhibitory activity as well as significant cytotoxicity in vitro. In addition, oleandrigenin 2 compared to derivatives 21 and 25 induced strong apoptosis in human cervical carcinoma HeLa cells after 24 h of treatment.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
<a href="/en/project/EF16_019%2F0000868" target="_blank" >EF16_019/0000868: Molecular, cellular and clinical approach to healthy ageing</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
ISSN
0223-5234
e-ISSN
—
Volume of the periodical
202
Issue of the periodical within the volume
SEP
Country of publishing house
FR - FRANCE
Number of pages
13
Pages from-to
"112520-1"-"112520-13"
UT code for WoS article
000560369900017
EID of the result in the Scopus database
2-s2.0-85087430809